3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Follicular
17
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Mantle-Cell
6
Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma, B-Cell
3
Leukemia
3
Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Tumor Lysis Syndrome
1
Solid Tumors
1
Recurrence
1
Oncology Patients Receiving Chemotherapy
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphoid
1
Leukemia, Hairy Cell
1
Indolent Non-Hodgkin's Lymphoma
1
Chromosome 17 deletion
1
Carcinoma, Non-Small-Cell Lung
1
B-cell Malignancies
1
Anemia
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
obinutuzumab
×
Clear all
No trials found.